Whittier Trust Co. of Nevada Inc. held its stake in shares of Aetna Inc. (NYSE:AET) during the second quarter, Holdings Channel reports. The fund owned 3,515 shares of the company’s stock at the end of the second quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Aetna were worth $429,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. DAVENPORT & Co LLC increased its position in Aetna by 0.3% in the second quarter. DAVENPORT & Co LLC now owns 5,761 shares of the company’s stock worth $704,000 after buying an additional 18 shares during the period. Rehmann Capital Advisory Group increased its position in Aetna by 1.2% in the second quarter. Rehmann Capital Advisory Group now owns 2,209 shares of the company’s stock worth $270,000 after buying an additional 26 shares during the period. Evanson Asset Management LLC increased its position in Aetna by 2.6% in the second quarter. Evanson Asset Management LLC now owns 1,951 shares of the company’s stock worth $238,000 after buying an additional 50 shares during the period. Pitcairn Co. increased its position in Aetna by 1.1% in the second quarter. Pitcairn Co. now owns 5,229 shares of the company’s stock worth $639,000 after buying an additional 55 shares during the period. Finally, Cullen Frost Bankers Inc. increased its position in Aetna by 2.9% in the second quarter. Cullen Frost Bankers Inc. now owns 2,572 shares of the company’s stock worth $314,000 after buying an additional 72 shares during the period. Hedge funds and other institutional investors own 91.95% of the company’s stock.
Aetna Inc. (NYSE:AET) traded up 0.97% on Monday, reaching $114.82. The company’s stock had a trading volume of 797,272 shares. Aetna Inc. has a 1-year low of $92.42 and a 1-year high of $123.57. The firm’s 50 day moving average price is $116.09 and its 200-day moving average price is $115.79. The company has a market capitalization of $40.28 billion, a price-to-earnings ratio of 16.83 and a beta of 0.54.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, August 2nd. The company reported $2.21 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.12 by $0.09. The firm earned $15.95 billion during the quarter, compared to analyst estimates of $15.69 billion. Aetna had a return on equity of 16.44% and a net margin of 3.89%. The business’s revenue for the quarter was up 4.7% compared to the same quarter last year. During the same period in the previous year, the company posted $2.05 EPS. Equities analysts forecast that Aetna Inc. will post $8.05 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.88%. The ex-dividend date of this dividend is Tuesday, October 11th. Aetna’s payout ratio is 14.73%.
A number of equities analysts have issued reports on AET shares. Credit Suisse Group AG reiterated a “hold” rating and issued a $120.00 price objective on shares of Aetna in a report on Tuesday, September 13th. Evercore ISI assumed coverage on Aetna in a report on Thursday, September 22nd. They issued a “buy” rating and a $128.00 price objective for the company. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $128.00 target price on the stock in a research note on Tuesday, October 4th. Leerink Swann reissued an “outperform” rating on shares of Aetna in a research note on Wednesday, August 24th. Finally, Wolfe Research assumed coverage on Aetna in a research note on Tuesday, June 28th. They issued an “outperform” rating and a $154.00 target price on the stock. Six research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $132.43.
In other news, insider Shawn M. Guertin sold 45,328 shares of the business’s stock in a transaction on Tuesday, August 23rd. The stock was sold at an average price of $120.21, for a total value of $5,448,878.88. Following the completion of the transaction, the insider now directly owns 44,883 shares of the company’s stock, valued at approximately $5,395,385.43. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Jeffrey E. Garten sold 7,100 shares of the business’s stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total value of $827,221.00. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.